---
figid: PMC6446925__nihms-1019768-f0001
figtitle: AMPK Signaling Pathway
organisms:
- NA
pmcid: PMC6446925
filename: nihms-1019768-f0001.jpg
figlink: /pmc/articles/PMC6446925/figure/F1/
number: F1
caption: The AMPK Signaling Pathway. Schematic model depicts the main upstream regulators
  and downstream effectors of AMPK. Potential link to AD is indicated. Arrows denote
  activation and blunted lines indicate inhibition. Refer to the main text for details.
papertitle: Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimerâ€™s Disease.
reftext: Xin Wang, et al. J Alzheimers Dis. 2019;68(1):33-38.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.951667
figid_alias: PMC6446925__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6446925__F1
ndex: a9d3e72f-def2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6446925__nihms-1019768-f0001.html
  '@type': Dataset
  description: The AMPK Signaling Pathway. Schematic model depicts the main upstream
    regulators and downstream effectors of AMPK. Potential link to AD is indicated.
    Arrows denote activation and blunted lines indicate inhibition. Refer to the main
    text for details.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ad
  - ab
  - Appl
  - Lkb1
  - Decay
  - Akt
  - Tak1
  - Pen
  - alphaTub85E
  - Prosalpha2
  - nAChRalpha2
  - Col4a1
  - Ca-alpha1D
  - alphaTub84B
  - nAChRalpha1
  - wb
  - Prosalpha1
  - br
  - sgg
  - SNF4Agamma
  - AMPKalpha
  - eEF2
  - CG4849
  - Crtc
  - APP
  - SUCLA2
  - STK11
  - AKT1
  - AKT2
  - AKT3
  - CAMKK2
  - MAP3K7
  - NR2C2
  - GPR162
  - ADRA1D
  - AA2
  - GSK3A
  - GSK3B
  - EEF2K
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - EEF2
  - MTOR
  - RPTOR
  - TRO
  - AD
---
